Vega-García, N., & Pérez Martínez, A. (2021). Measurable residual disease assessed by flow-cytometry is a stable prognostic factor for pediatric t-cell acute lymphoblastic leukemia in consecutive SEHOP protocols whereas the impact of oncogenetics depends on treatment.
Chicago Style CitationVega-García, Nerea, and Antonio Pérez Martínez. Measurable Residual Disease Assessed By Flow-cytometry Is a Stable Prognostic Factor for Pediatric T-cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends On Treatment. 2021.
MLA CitationVega-García, Nerea, and Antonio Pérez Martínez. Measurable Residual Disease Assessed By Flow-cytometry Is a Stable Prognostic Factor for Pediatric T-cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends On Treatment. 2021.